TARGTEPO

Welcome to the Brand page for “TARGTEPO”, which is offered here for Biological materials, genetically modified autologous tissue implants, intended to produce proteins for therapeutic uses;medical services, harvesting tissue from a patient, genetically modifying that tissue and then reintroducing it into the same patient for therapeutic purposes;medical devices and instruments for genetically modifying tissue;.

Its status is currently believed to be active. Its class is unavailable. “TARGTEPO” is believed to be currently owned by “AEVI GENOMIC MEDICINE, INC.”